• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 144 filed by MetLife Inc.

    6/20/25 4:43:46 PM ET
    $MET
    Life Insurance
    Finance
    Get the next $MET alert in real time by email
    Form 144 Filer Information UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Form 144

    NOTICE OF PROPOSED SALE OF SECURITIES
    PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933

    FORM 144

    144: Filer Information

    Filer CIK
    0000728618
    Filer CCC
    XXXXXXXX
    Is this a LIVE or TEST Filing? Radio button checked LIVE Radio button not checked TEST

    Submission Contact Information

    Name
    Phone
    E-Mail Address

    144: Issuer Information

    Name of Issuer
    METLIFE INC
    SEC File Number
    001-15787
    Address of Issuer
    200 Park Avenue
    New York
    NEW YORK
    10016
    Phone
    212-578-2211
    Name of Person for Whose Account the Securities are To Be Sold
    MetLife Separate Account SPI
    See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

    Relationship to Issuer
    Affiliate

    144: Securities Information

    Title of the Class of Securities To Be SoldName and Address of the BrokerNumber of Shares or Other Units To Be SoldAggregate Market ValueNumber of Shares or Other Units OutstandingApproximate Date of SaleName the Securities Exchange
    Common Stock
    Barclays Capital
    745 Seventh Ave
    New York � NY � 10019
    3602827867129782606/20/2025
    NYSE


    Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

    144: Securities To Be Sold

    Title of the ClassDate you AcquiredNature of Acquisition TransactionName of Person from Whom AcquiredIs this a Gift?Date Donor AcquiredAmount of Securities AcquiredDate of PaymentNature of Payment *
    Common Stock05/29/2015PurchaseGOLDMAN SACHSCheckbox not checked36006/03/2015Cash

    * If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



    Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

    144: Securities Sold During The Past 3 Months

    Name and Address of SellerTitle of Securities SoldDate of SaleAmount of Securities SoldGross Proceeds
    MetLife 401k Plan Trust-Large Cap Equity Index
    1 Metlife Way
    Whippany � NJ � 07981
    Common Stock03/21/202533527590.6
    Separate Account SPI
    1 Metlife Way
    Whippany � NJ � 07981
    Common Stock03/21/2025776341.72
    Separate Account II
    1 Metlife Way
    Whippany � NJ � 07981
    Common Stock03/21/2025473870.92
    Separate Account 149
    1 Metlife Way
    Whippany � NJ � 07981
    Common Stock03/21/20256494.16
    Separate Account II
    1 Metlife Way
    Whippany � NJ � 07981
    Common Stock06/13/202522117094.35

    144: Remarks and Signature

    Remarks
    Date of Notice
    06/20/2025

    ATTENTION:

    The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
    Signature
    Mirsad Usejnoski

    ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

    Get the next $MET alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MET

    DatePrice TargetRatingAnalyst
    1/23/2025$97.00Market Perform
    BMO Capital Markets
    10/9/2024$97.00Buy
    TD Cowen
    9/5/2024$91.00Overweight
    Barclays
    1/8/2024$80.00Neutral → Buy
    Goldman
    11/17/2023$71.00Overweight
    Barclays
    10/5/2023$71.00Hold
    Deutsche Bank
    9/14/2023$58.00 → $72.00Hold → Buy
    Jefferies
    1/9/2023$80.00 → $78.00Buy → Neutral
    Goldman
    More analyst ratings

    $MET
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • BMO Capital Markets initiated coverage on MetLife with a new price target

      BMO Capital Markets initiated coverage of MetLife with a rating of Market Perform and set a new price target of $97.00

      1/23/25 7:50:09 AM ET
      $MET
      Life Insurance
      Finance
    • TD Cowen initiated coverage on MetLife with a new price target

      TD Cowen initiated coverage of MetLife with a rating of Buy and set a new price target of $97.00

      10/9/24 7:52:22 AM ET
      $MET
      Life Insurance
      Finance
    • Barclays initiated coverage on MetLife with a new price target

      Barclays initiated coverage of MetLife with a rating of Overweight and set a new price target of $91.00

      9/5/24 8:14:53 AM ET
      $MET
      Life Insurance
      Finance